Arbutus Biopharma (ABUS) Restructuring Costs (2015 - 2025)
Arbutus Biopharma (ABUS) posted quarterly Restructuring Costs of $303000.0 for Q4 2025, up 218.95% year-on-year from $95000.0 in Q4 2024, and up 209.18% on a QoQ basis from $98000.0 in Q3 2025.
Arbutus Biopharma (ABUS) Restructuring Costs (2015 - 2025) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Restructuring Costs for 6 consecutive years, with $303000.0 the latest figure, recorded in Q4 2025.
- Quarterly Restructuring Costs rose 218.95% year-over-year to $303000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $12.8 million (down 20.46% YoY) and the FY2025 annual result came in at $12.9 million, up 247.82% from the prior year.
- Restructuring Costs advanced to $303000.0 in Q4 2025 per ABUS's latest filing, from $98000.0 in the prior quarter.
- Over the last five years, Restructuring Costs for ABUS reached as high as $12.4 million in Q2 2025 and fell as low as $95000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 12.40 Mn |
| Mar 31, 2025 | 12.37 Mn |
| Dec 31, 2024 | 95,000.00 |
| Sep 30, 2024 | 3.63 Mn |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 57,000.00 |
| Dec 31, 2019 | 123,000.00 |
| Sep 30, 2019 | 182,000.00 |
| Jun 30, 2019 | -266,000.00 |
| Mar 31, 2019 | 4.90 Mn |
| Dec 31, 2018 | 1.09 Mn |
| Sep 30, 2018 | -492,000.00 |
| Jun 30, 2018 | 2.58 Mn |
| Mar 31, 2018 | 1.62 Mn |
| Jun 30, 2015 | 361,000.00 |
| Mar 31, 2015 | 9.30 Mn |